Kaplan–Meier analysis showed that AITL patients carrying two or more pathogenic TET2 mutations with high allelic burden (the first subgroup) had significantly shorter time in development of CHN (p-value=0.0006; Figure 4). The gene discussed is TET2; the disease is neuropathy, congenital hypomelinating.